本頁面由Tiger Trade Technology Pte. Ltd.提供服務

10x Genomics, Inc.

16.94
+0.89005.55%
盤前16.75-0.1900-1.12%08:15 EST
成交量:227.49萬
成交額:3,822.57萬
市值:21.44億
市盈率:-27.38
高:16.97
開:16.05
低:15.90
收:16.05
52周最高:20.34
52周最低:6.78
股本:1.27億
流通股本:1.12億
量比:1.05
換手率:2.02%
股息:- -
股息率:- -
每股收益(TTM):-0.6186
每股收益(LYR):-1.5162
淨資產收益率:-10.12%
總資產收益率:-8.42%
市淨率:2.73
市盈率(LYR):-11.17

資料載入中...

2024/06/13

重要事件披露

Form 8-K - Current report
2024/05/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/30

重要事件披露

Form 8-K - Current report
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/15

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/17

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities